News Conference News EHRA 2019 Thromboembolic Risks High in Patients With A-fib, Valvular Disease Todd Neale March 25, 2019
News Industry News Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study June 22, 2015